Insulin Resistance and Severity of Coronary Artery Disease

HOMA Estimated Insulin Resistance as a Marker for Angiographic Severity of Coronary Artery Disease in Non Diabetic & Non Obese Patients.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05215821

Enrollment

112

Registered

2022-01-31

Start date

2021-02-01

Completion date

2022-02-28

Last updated

2022-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance

Brief summary

this is an observertional study aimed at Study the association between Insulin resistance estimated by HOMA and Angiographic Severity of Coronary Artery Disease in Non Diabetic & Non Obese Patients.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* patients undergoing coronary angiography (CA) for ACS or stable angina in the Catheterization Laboratory of internal Medicine department and El Noor specialized cardiac center at the study period.

Exclusion criteria

* age \< 18 years, * pregnancy or breastfeeding, * BMI \>30 Kg/m2 and * presence of pre-diabetes or overt diabetes.

Design outcomes

Primary

Measure	Time frame
HOMA IR level estimated by Two-site immunoenzymometric assay	4 months

Countries

Egypt

Contacts

Primary ContactAli mo Altaher, lecturer

dr.ali.altaher30@gmail.com01003376529

Outcome results